Company intelligence / Profile preview

Treace Medical Concepts

Ponte Vedra Beach, Florida, United Statestreace.com ↗

Ownership: Public · TMCI
Development stage: Commercial

Overview

Treace’s Lapiplasty® system has been used in over 100,000 procedures with strong clinical outcomes—97%-99% of patients maintained their 3D bunion correction at follow-up. The company’s portfolio includes multiple FDA-cleared devices for surgical management of complex foot and ankle deformities. Clinical data from the ALIGN3D™ study and other publications support efficacy and rapid return to weight-bearing[1][6][9][10].

Therapeutic areas: Other
Modalities: Device
Industry: Surgical Medical Devices

Financials

Market cap: $293.9M
Total revenue: $45.4M
Enterprise value: $320.9M

Beyond the preview

Go deeper on Treace Medical Concepts.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Treace Medical Concepts.

Explore the full profile